Regenxbio Inc (RGNX)
11.14
+0.47
(+4.40%)
USD |
NASDAQ |
Nov 14, 16:00
11.58
+0.44
(+3.95%)
After-Hours: 20:00
Regenxbio Total Return Level: 11.14 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 11.14 |
November 13, 2024 | 10.67 |
November 12, 2024 | 10.49 |
November 11, 2024 | 11.56 |
November 08, 2024 | 11.16 |
November 07, 2024 | 11.19 |
November 06, 2024 | 9.43 |
November 05, 2024 | 8.92 |
November 04, 2024 | 8.76 |
November 01, 2024 | 8.79 |
October 31, 2024 | 8.59 |
October 30, 2024 | 8.84 |
October 29, 2024 | 9.06 |
October 28, 2024 | 9.38 |
October 25, 2024 | 9.35 |
October 24, 2024 | 9.58 |
October 23, 2024 | 9.74 |
October 22, 2024 | 9.59 |
October 21, 2024 | 10.37 |
October 18, 2024 | 11.10 |
October 17, 2024 | 10.60 |
October 16, 2024 | 10.75 |
October 15, 2024 | 10.30 |
October 14, 2024 | 10.20 |
October 11, 2024 | 9.89 |
Date | Value |
---|---|
October 10, 2024 | 9.29 |
October 09, 2024 | 9.24 |
October 08, 2024 | 9.56 |
October 07, 2024 | 9.52 |
October 04, 2024 | 9.72 |
October 03, 2024 | 9.35 |
October 02, 2024 | 9.92 |
October 01, 2024 | 10.21 |
September 30, 2024 | 10.49 |
September 27, 2024 | 10.80 |
September 26, 2024 | 10.68 |
September 25, 2024 | 10.83 |
September 24, 2024 | 11.21 |
September 23, 2024 | 11.67 |
September 20, 2024 | 11.69 |
September 19, 2024 | 12.50 |
September 18, 2024 | 12.53 |
September 17, 2024 | 12.95 |
September 16, 2024 | 12.74 |
September 13, 2024 | 12.84 |
September 12, 2024 | 12.18 |
September 11, 2024 | 12.71 |
September 10, 2024 | 11.79 |
September 09, 2024 | 11.40 |
September 06, 2024 | 11.48 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
8.59
Minimum
Oct 31 2024
54.20
Maximum
Feb 13 2020
27.39
Average
27.04
Median
Total Return Level Benchmarks
Catalyst Pharmaceuticals Inc | 21.69 |
EyePoint Pharmaceuticals Inc | 10.49 |
Cassava Sciences Inc | 44.19 |
Vertex Pharmaceuticals Inc | 483.96 |
Sarepta Therapeutics Inc | 109.11 |